Citadel Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $61.9K | Sell |
39,700
-45,600
| -53% | -$66.3K | ﹤0.01% | 12314 |
|
|
2025
Q4 | $98.1K | Sell |
85,300
-11,300
| -12% | -$15.5K | ﹤0.01% | 11657 |
|
|
2025
Q3 | $130K | Buy |
96,600
+46,300
| +92% | +$52.5K | ﹤0.01% | 11643 |
|
|
2025
Q2 | $47.6K | Sell |
50,300
-12,700
| -20% | -$8.23K | ﹤0.01% | 11794 |
|
|
2025
Q1 | $29K | Sell |
63,000
-94,300
| -60% | -$59.5K | ﹤0.01% | 12858 |
|
|
2024
Q4 | $116K | Buy |
157,300
+34,100
| +28% | +$41.1K | ﹤0.01% | 11234 |
|
|
2024
Q3 | $193K | Buy |
123,200
+26,200
| +27% | +$46.7K | ﹤0.01% | 10199 |
|
|
2024
Q2 | $163K | Sell |
97,000
-2,700
| -3% | -$4.84K | ﹤0.01% | 10217 |
|
|
2024
Q1 | $239K | Buy |
99,700
+21,200
| +27% | +$45.5K | ﹤0.01% | 9944 |
|
|
2023
Q4 | $120K | Buy |
78,500
+2,700
| +4% | +$3.21K | ﹤0.01% | 10697 |
|
|
2023
Q3 | $82.6K | Sell |
75,800
-39,400
| -34% | -$69.1K | ﹤0.01% | 11127 |
|
|
2023
Q2 | $264K | Buy |
115,200
+77,600
| +206% | +$206K | ﹤0.01% | 9317 |
|
|
2023
Q1 | $91.4K | Buy |
37,600
+34,000
| +944% | +$77.9K | ﹤0.01% | 11390 |
|
|
2022
Q4 | $6.88K | Buy |
+3,600
| New | +$7.66K | ﹤0.01% | 13876 |
|
|
2022
Q3 | – | Sell |
-41,200
| Closed | -$77K | – | 13197 |
|
|
2022
Q2 | $77K | Buy |
+41,200
| New | +$78.6K | ﹤0.01% | 11626 |
|
|
2022
Q1 | – | Sell |
-32,500
| Closed | -$128K | – | 14177 |
|
|
2021
Q4 | $128K | Buy |
32,500
+12,300
| +61% | +$59.7K | ﹤0.01% | 12460 |
|
|
2021
Q3 | $97K | Sell |
20,200
-6,200
| -23% | -$25.4K | ﹤0.01% | 12914 |
|
|
2021
Q2 | $121K | Sell |
26,400
-29,400
| -53% | -$142K | ﹤0.01% | 12736 |
|
|
2021
Q1 | $328K | Buy |
55,800
+14,200
| +34% | +$98.3K | ﹤0.01% | 10633 |
|
|
2020
Q4 | $142K | Buy |
41,600
+24,800
| +148% | +$47.3K | ﹤0.01% | 9986 |
|
|
2020
Q3 | $24K | Buy |
+16,800
| New | +$29.9K | ﹤0.01% | 9817 |
|
|
2020
Q2 | – | Sell |
-10,000
| Closed | -$20K | – | 10216 |
|
|
2020
Q1 | $20K | Sell |
10,000
-100
| -1% | -$298 | ﹤0.01% | 9302 |
|
|
2019
Q4 | $42K | Sell |
10,100
-3,500
| -26% | -$13.5K | ﹤0.01% | 8799 |
|
|
2019
Q3 | $41K | Buy |
13,600
+1,400
| +11% | +$4.33K | ﹤0.01% | 8760 |
|
|
2019
Q2 | $77K | Sell |
12,200
-274,900
| -96% | -$1.65M | ﹤0.01% | 8611 |
|
|
2019
Q1 | $1.6M | Buy |
287,100
+268,600
| +1,452% | +$1.63M | ﹤0.01% | 4826 |
|
|
2018
Q4 | $123K | Sell |
18,500
-15,800
| -46% | -$128K | ﹤0.01% | 8155 |
|
|
2018
Q3 | $366K | Buy |
34,300
+22,600
| +193% | +$259K | ﹤0.01% | 7240 |
|
|
2018
Q2 | $140K | Buy |
+11,700
| New | +$120K | ﹤0.01% | 8104 |
|
|
2018
Q1 | – | Sell |
-13,000
| Closed | -$128K | – | 8564 |
|
|
2017
Q4 | $128K | Sell |
13,000
-3,000
| -19% | -$31.2K | ﹤0.01% | 7337 |
|
|
2017
Q3 | $197K | Buy |
+16,000
| New | +$236K | ﹤0.01% | 6706 |
|
|
2016
Q4 | – | Sell |
-11,500
| Closed | -$208K | – | 7597 |
|
|
2016
Q3 | $208K | Buy |
+11,500
| New | +$185K | ﹤0.01% | 6252 |
|
|
2015
Q4 | – | Sell |
-600
| Closed | -$6K | – | 8984 |
|
|
2015
Q3 | $6K | Buy |
+600
| New | +$6.55K | ﹤0.01% | 8597 |
|
Other funds holding LXRX
AG
SL
SC
VCM
